As managed care made inroads in the American health care scene in the early 1990s, most everyone in the drug industry believed that generics would become a dominant force, with unstoppable growth. Everyone was wrong.
According to IMS America Ltd., only about 30% of all new prescriptions are filled generically—about the same as it was...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?